Company Profile

FERMENTA BIOTECH LTD.

NSE : NABSE : 506414ISIN CODE : INE225B01021Industry : MiscellaneousHouse : Private
BSE243.453.3 (+1.37 % )
PREV CLOSE (Rs.) 240.15
OPEN PRICE (Rs.) 238.50
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 16402
TODAY'S LOW / HIGH (Rs.)237.30 248.00
52 WK LOW / HIGH (Rs.) 151 337
NSE
This Company is not listed in NSE

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.17
TTM EPS (Rs.) 20.10
P/E Ratio 12.11
Book Value (Rs.) 107.82
Face Value (Rs.) 5
MCap (Rs. in Mn) 7164.97
Price/Earning (TTM) 10.44
Price/Sales (TTM) 4.54
Price/Book (MRQ) 2.26
PAT Margin (%) -13.80
ROCE (%) -4.71
Incorporation Year : 1951

Management Info :

Sanjay Buch - Chairman Krishna Datla - Managing Director

Registered Office :

Address : A 1601, Thane One,Dil Complex, Ghodbhunder Road,Majiwada,
Thane,
Maharashtra-400610

Phone : 022 6623 0800

Email : contact@dil.net

Website : www.dil.net

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE
NEWS More
02Apr04-02-2020$Fermenta Biotech informs about change in directorate Fermenta Biotech informs abo

Fermenta Biotech has informed that in terms of Section 149, 150, 152 and 161 of the Companies Act, 2013 and Regulation 17 and other applicable provisions of Listing Regulations, the Board members of the Company, on April 1, 2020, have appointed Rajashri Santosh Kumar Ojha (DIN: 07058128) as an Additional (Independent) Director on the Board of Directors of the Company with effect from April 1, 2020.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech has informed that in terms of Section 149, 150..
12Feb02-12-2020$Fermenta Biotech informs about earnings release Fermenta Biotech informs abo

Further to intimation regarding approval of Unaudited Financial Results (Standalone and Consolidated) by the Board of Directors for the quarter and nine months ended December 31, 2019, Fermenta Biotech has informed that it has enclosed a copy of Earnings Release of the Company for the quarter and nine months ended December 31, 2019. The said Earnings Release is also available on Company's website www.dil.net.

The above information is a part of company’s filings submitted to BSE.

Further to intimation regarding approval of Unaudited Financial..
12Feb02-12-2020$Fermenta Biotech informs about outcome of board meeting Fermenta Biotech informs abo

Fermenta Biotech has informed that the Board of Directors of the Company at its meeting held on February 12, 2020 has approved the unaudited financial results for the quarter and nine months ended December 31, 2019 (Standalone and Consolidated) as enclosed. Also enclosed herewith Limited Review Report dated February 12, 2020 (along with the aforesaid Consolidated and Standalone unaudited financial Results) issued by the Companys Statutory Auditors, Deloitte Haskins & Sells LLP. The Board meeting commenced at 10:45 am and concluded at 12:55 pm.

The above information is a part of company’s filings submitted to BSE.

Fermenta Biotech has informed that the Board of Directors of th..
30Dec12-30-2019$Fermenta Biotech informs about postal ballot notice Fermenta Biotech informs abo

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Fermenta Biotech has informed that it has submitted the Postal Ballot Notice dispatched to the members of the Company on December 30, 2019 whose names appeared in the Register of Beneficial Owners maintained by the depositories or in the Register of Members as on cut-off date; Thursday, December 26, 2019 (Cut-off date). The Postal Ballot Notice dated December 24, 2019 is available on the website of the Company at www.dil.net

The above information is a part of company’s filings submitted to BSE.


Pursuant to Regulation 30 of the Securities and Exchange Board..
10Dec12-10-2019$Fermenta Biotech informs about non-deal roadshow Fermenta Biotech informs abo

Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Fermenta Biotech has informed that the Company officials are participating in the Non-Deal Roadshow organized by YES Securities (India) on 11th December 2019 at Mumbai.

The above information is a part of company’s filings submitted to BSE.

Pursuant to the relevant provisions of SEBI (Listing Obligation..
Financials More
Rs. in Millions
QTR Dec 19 ANNUAL 19
Net Profit97.5200000000001-26.71
Gross Profit 81.9400000000001 -256.49
Operating Profit 173.85-59.03
Net Sales 664.52193.54
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Evans Electric (BSE)
 250.00 (10.13%)
M.Cap ( in Cr)
34.30
Just Dial (BSE)
 392.60 (3.85%)
M.Cap ( in Cr)
2548.12
Gaurav Mercantiles (BSE)
 376.85 (3.76%)
M.Cap ( in Cr)
75.37
Quess Corp (BSE)
 221.55 (5.00%)
M.Cap ( in Cr)
3269.71
Syngene Internation. (BSE)
 356.85 (1.86%)
M.Cap ( in Cr)
14274.00
Shareholding Pattern More
PROMOTERS 59.44 %
NON-INSTITUTION 40.04 %
FI/BANKS/INSURANCE 0 %
MUTUAL FUNDS/UTI 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes